Sandostatine® LP and Hyperinsulinism

This study has been completed.
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT00987168
First received: September 29, 2009
Last updated: December 18, 2013
Last verified: October 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2011
  Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)